The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Joanna J. Wykrzykowska
Showing 1-20 of 62 articles
Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial
Ono M,
Hara H,
Kawashima H,
Gao C,
Wang R,
Wykrzykowska JJ,
Piek J,
Garg S,
Hamm C,
Steg PG,
Valgimigli M,
Windecker S,
Vranckx P,
Onuma Y,
Serruys P
August 5, 2022 | 10.4244/EIJ-D-21-00870
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial
Kerkmeijer L,
Renkens M,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Garcia-Garcia H,
Kraak R,
Piek J,
Tijssen J,
Henriques JP,
de Winter RJ,
Wykrzykowska JJ
March 18, 2022 | 10.4244/EIJ-D-21-00419
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study
Milewski K,
Takahashi K,
Asano T,
Katagiri Y,
Hochul M,
Buszman P,
Tomaniak M,
Gorycki B,
Zurakowski A,
Janas A,
Mlodziankowski A,
Kachel M,
Wykrzykowska JJ,
Wijns W,
de Winter RJ,
Buszman P,
Onuma Y,
Serruys P
February 19, 2021 | 10.4244/EIJ-D-18-01201
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial
Kraak R,
Tijssen R,
van Dongen I,
Elias J,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Tijssen J,
Piek J,
de Winter RJ,
Henriques JP,
Wykrzykowska JJ
December 4, 2020 | 10.4244/EIJ-D-18-00884
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska JJ,
de Winter RJ,
Hamm C,
Steg PG,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Quantitative aortography assessment of aortic regurgitation
Modolo R,
Chang C,
Onuma Y,
Schultz C,
Tateishi H,
Abdelghani M,
Miyazaki Y,
Aben J,
Rutten M,
Pighi M,
El Bouziani A,
van Mourik M,
Lemos P,
Wykrzykowska JJ,
Brito F,
Sahyoun C,
Piazza N,
Eltchaninoff H,
Soliman O,
Abdel-Wahab M,
Van Mieghem N,
de Winter RJ,
Serruys P
October 9, 2020 | 10.4244/EIJ-D-19-00879
Complex PCI: time for a universal definition
Wykrzykowska JJ,
Kerkmeijer L
September 18, 2020 | 10.4244/EIJV16I7A100
Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.
Katagiri Y,
Torii R,
Takahashi K,
Tenekecioglu E,
Asano T,
Chichareon P,
Tomaniak M,
Piek J,
Wykrzykowska JJ,
Bullett N,
Ahmed N,
Al-Lamee R,
Al-Lamee R,
Leclerc G,
Kitslaar P,
Dijkstra J,
Reiber J,
Poon E,
Bourantas C,
Gijsen F,
Serruys P,
Onuma Y
June 12, 2020 | 10.4244/EIJ-D-18-01190
Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial
Katagiri Y,
Onuma Y,
Lurz P,
Buszman P,
Piek J,
Wykrzykowska JJ,
Asano T,
Kogame N,
Takahashi K,
Chang C,
de Winter RJ,
Serruys P,
Wijns W
February 7, 2020 | 10.4244/EIJ-D-18-00944
Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation
Katagiri Y,
Serruys P,
Tenekecioglu E,
Asano T,
Collet C,
Miyazaki Y,
Katsikis A,
Piek J,
Wykrzykowska JJ,
Chevalier B,
Mintz G,
Stone G,
Onuma Y
September 20, 2019 | 10.4244/EIJ-D-18-00422
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
Kerkmeijer L,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout K,
Kraak R,
Weevers A,
Piek J,
de Winter RJ,
Tijssen J,
Henriques J,
Wykrzykowska JJ,
Ijsselmuiden A,
Kauer F,
Beijk MA,
Vis MM,
Koch K
September 20, 2019 | 10.4244/EIJ-D-19-00325
Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE Registry
Modolo R,
Chang C,
Tateishi H,
Miyazaki Y,
Pighi M,
Abdelghani M,
Roos M,
Wolff Q,
Wykrzykowska JJ,
de Winter RJ,
Piazza N,
Richardt G,
Abdel-Wahab M,
Soliman O,
Onuma Y,
Van Mieghem N,
Serruys P
August 29, 2019 | 10.4244/EIJ-D-19-00362
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber C,
Sabaté M,
Iqbal J,
Wykrzykowska JJ,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg PG,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
Serruys P,
Farooq V,
Banning A,
Escaned J,
Wykrzykowska JJ,
Piek J,
Dudek D,
Ochala A,
Hildick-Smith D,
Goicolea J,
Iñiguez A,
Buszman P,
Modolo R,
Katagiri Y,
Kogame N,
Onuma Y
June 12, 2019 | 10.4244/EIJ-D-18-00980
How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials
Katagiri Y,
Serruys P,
Asano T,
Miyazaki Y,
Chichareon P,
Modolo R,
Takahashi K,
Kogame N,
Wykrzykowska JJ,
Piek J,
Onuma Y
May 20, 2019 | 10.4244/EIJ-D-18-00607
A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial
Asano T,
Jin Q,
Katagiri Y,
Kogame N,
Takahashi K,
Chang C,
Chichareon P,
Wang C,
Shi B,
Su X,
Fu G,
Wu Y,
Zhou X,
Yuan Z,
Wykrzykowska JJ,
Piek J,
Serruys P,
Onuma Y,
Chen Y
December 20, 2018 | 10.4244/EIJ-D-18-00461
Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study
van Zandvoort L,
Dudek D,
Weber-Albers J,
Abizaid A,
Christiansen E,
Muller D,
Kochman J,
Kołtowski Ł,
Lassen J,
Wojdyla R,
Wykrzykowska JJ,
Onuma Y,
Daemen J
December 7, 2018 | 10.4244/EIJ-D-18-00491
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Katagiri Y,
Onuma Y,
Asano T,
Chichareon P,
Collet C,
Miyazaki Y,
Piek J,
Wykrzykowska JJ,
Abizaid A,
Ormiston J,
Chevalier B,
Serruys P
October 12, 2018 | 10.4244/EIJ-D-18-00301
Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial
Sotomi Y,
Onuma Y,
Liu S,
Asano T,
Eggermont J,
Katagiri Y,
Cavalcante R,
de Winter RJ,
Wykrzykowska JJ,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Dijkstra J,
Serruys P
August 24, 2018 | 10.4244/EIJ-D-17-00884
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T,
Katagiri Y,
Collet C,
Tenekecioglu E,
Miyazaki Y,
Sotomi Y,
Amoroso G,
Aminian A,
Brugaletta S,
Vrolix M,
Hernández-Antolín R,
van de Harst P,
Iñiguez A,
Janssens L,
Smits P,
Wykrzykowska JJ,
Ribeiro V,
Pereira H,
da Silva P,
Piek J,
Reiber J,
von Birgelen C,
Sabaté M,
Onuma Y,
Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00461
1
2
3
…
4
Latest news
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
AHEAD OF PRINT
One-year outcomes with the Mistral device
FREE ARTICLE - Kerstin Piayda et al
March 13, 2023
AHEAD OF PRINT
Navitor CE mark cohort outcomes
FREE ARTICLE - Lars Sondergaard et al
March 9, 2023
AHEAD OF PRINT
One-year SAPIEN 3U registry results
FREE ARTICLE - Stefano Cannata et al
March 7, 2023
AHEAD OF PRINT
The POT-PUFF sign: an angiographic mark of stent malapposition during proximal optimisation
FREE ARTICLE - Farhang Aminfar et al
March 3, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke